These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11290819)

  • 1. ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits.
    Aragane K; Fujinami K; Kojima K; Kusunoki J
    J Lipid Res; 2001 Apr; 42(4):480-8. PubMed ID: 11290819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of F-1394, an acyl-CoA:cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits.
    Aragane K; Kojima K; Fujinami K; Kamei J; Kusunoki J
    Atherosclerosis; 2001 Sep; 158(1):139-45. PubMed ID: 11500184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein secretion.
    Aragane K; Kusunoki J; Kitamine T; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1998 Mar; 76(3):309-12. PubMed ID: 9593225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
    Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
    Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity.
    Kusunoki J; Aragane K; Kitamine T; Kozono H; Kano K; Fujinami K; Kojima K; Chiwata T; Sekine Y
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):171-8. PubMed ID: 10634814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
    Kusunoki J; Aragane K; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.
    Rival Y; Junquéro D; Bruniquel F; N'Guyen X; Fauré P; Pomiès JP; Degryse AD; Delhon A
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):181-91. PubMed ID: 11791003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocholesterolemic action and prevention of cholesterol absorption via the gut by F-1394, a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, in cholesterol diet-fed rats.
    Kusunoki J; Aragane K; Kitamine T; Higashinakagawa S; Kase N; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Sep; 69(1):53-60. PubMed ID: 8847832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Yakugaku Zasshi; 1997 Apr; 117(4):233-41. PubMed ID: 9167444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I: role of the macrophage and platelet-derived growth factor.
    Rubin P; Williams JP; Riggs PN; Bartos S; Sarac T; Pomerantz R; Castano J; Schell M; Green RM
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):929-41. PubMed ID: 9531379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.
    Ameli S; Hultgardh-Nilsson A; Cercek B; Shah PK; Forrester JS; Ageland H; Nilsson J
    Circulation; 1994 Oct; 90(4):1935-41. PubMed ID: 7923682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of balloon-induced arterial injury with hyperlipidemia despite gemfibrozil.
    Lundgren C; Sobel BE; Fujii S
    Jpn Heart J; 1996 Jan; 37(1):119-26. PubMed ID: 8632619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit.
    Ferns GA; Forster L; Stewart-Lee A; Konneh M; Nourooz-Zadeh J; Anggård EE
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11312-6. PubMed ID: 1454812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.